A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro
β¦ LIBER β¦
216 Treatment of advanced ovarian carcinoma with tamoxifen. a phase II trial
β Scribed by J. Pagel; C. Rose; S. Thorpe; I. Hald
- Book ID
- 116003668
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 99 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0022-4731
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Phase II trial of vinblastine in advance
β
Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani
π
Article
π
1990
π
Springer US
π
English
β 231 KB
A phase II trial of tamoxifen in hepatoc
β
Paul F. Engstrom; Bernard Levin; Charles G. Moertel; Allan Schutt
π
Article
π
1990
π
John Wiley and Sons
π
English
β 224 KB
π 2 views
Phase II trial of VP-16-213 in advanced
β
Brian L. Hillcoat; J.J. Campbell; Roger Pepperell; Michael A. Quinn; James F. Bi
π
Article
π
1985
π
Elsevier Science
π
English
β 304 KB
Phase II trial of amsacrine (m-AMSA) in
β
Dombernowsky, Per; Siegenthaler, Pierre; Somers, Reinier; Hansen, Heine HΓΈi
π
Article
π
1982
π
Elsevier Science
β 405 KB
Treatment of advanced colorectal carcino
β
Anthony F. Shields; Mark M. Zalupski; John L. Marshall; Neal J. Meropol
π
Article
π
2004
π
John Wiley and Sons
π
English
β 85 KB
π 2 views
## Abstract ## BACKGROUND The current study was designed to evaluate the antitumor activity and toxicity of capecitabine and oxaliplatin in previously untreated patients with advanced colorectal carcinoma. The primary endpoint of the study was to determine the objective response rate, and a second
Phase II trial of fulvestrant in the tre
β
S.G. Thomas; P.L. Judson; L.F. Carson; L.S. Downs Jr.; R.G. Ghebre; M.A. Geller;
π
Article
π
2008
π
Elsevier Science
π
English
β 86 KB